$Immuneering (IMRX.US)$ The analyst maintains a 12-month pri...
The analyst maintains a 12-month price target of $8, citing the company’s potential for significant data events expected in the near future. These events include multiple Phase 2 data sets for their lead asset IMM-1-104 and initial Phase 1/2 data for IMM-6-415. With a cash runway extending into the second half of 2025 and upcoming clinical data that could positively impact the stock,
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Our Existence is a projection from another dimension, We Create our own reality where anything is possible. GOD is all
162Followers
9Following
235Visitors
Follow
Papanice9167 : 12 months? Will it make an RS to turn it into 8 blocks